R. Alcalay, E. Giladi, C. Pick, and I. Gozes, Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze, Neuroscience Letters, vol.361, issue.1-3, pp.128-159, 2004.
DOI : 10.1016/j.neulet.2003.12.005

A. Alonso, B. Li, I. Grundke-iqbal, and K. Iqbal, Mechanism of Tau-Induced Neurodegeneration in Alzheimer Disease and Related Tauopathies, Current Alzheimer Research, vol.5, issue.4, pp.375-84, 2008.
DOI : 10.2174/156720508785132307

A. Andrieux, P. Salin, A. Schweitzer, M. Begou, B. Pachoud et al., Microtubule Stabilizer Ameliorates Synaptic Function and Behavior in a Mouse Model for Schizophrenia, Biological Psychiatry, vol.60, issue.11, pp.1224-1254, 2006.
DOI : 10.1016/j.biopsych.2006.03.048
URL : https://hal.archives-ouvertes.fr/inserm-00380045

A. Andrieux, P. Salin, M. Vernet, P. Kujala, J. Baratier et al., The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders, Genes & Development, vol.16, issue.18, pp.2350-64, 2002.
DOI : 10.1101/gad.223302

M. Bassan, R. Zamostiano, A. Davidson, A. Pinhasov, E. Giladi et al., Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide, Journal of Neurochemistry, vol.240, issue.3, pp.1283-93, 1999.
DOI : 10.1046/j.1471-4159.1999.0721283.x

G. Benitez-king, G. Ramirez-rodriguez, L. Ortiz, and I. Meza, The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia, Current Drug Target -CNS & Neurological Disorders, vol.3, issue.6, pp.515-548, 2004.
DOI : 10.2174/1568007043336761

R. Braga, M. Mendlowicz, R. Marrocos, and I. Figueira, Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life, Journal of Psychiatric Research, vol.39, issue.4, pp.409-423, 2005.
DOI : 10.1016/j.jpsychires.2004.09.003

N. De-bruin and B. Pouzet, Beneficial effects of galantamine on performance in the object recognition task in Swiss mice: Deficits induced by scopolamine and by prolonging the retention interval, Pharmacology Biochemistry and Behavior, vol.85, issue.1, pp.253-60, 2006.
DOI : 10.1016/j.pbb.2006.08.007

E. Denarier, A. Fourest-lieuvin, C. Bosc, F. Pirollet, A. Chapel et al., Nonneuronal isoforms of STOP protein are responsible for microtubule cold stability in mammalian fibroblasts, Proceedings of the National Academy of Sciences, vol.95, issue.11, pp.6055-60, 1998.
DOI : 10.1073/pnas.95.11.6055

I. Divinski, L. Mittelman, and I. Gozes, A Femtomolar Acting Octapeptide Interacts with Tubulin and Protects Astrocytes against Zinc Intoxication, Journal of Biological Chemistry, vol.279, issue.27, pp.28531-28539, 2004.
DOI : 10.1074/jbc.M403197200

S. Eastwood, L. Lyon, L. George, A. Andrieux, D. Job et al., Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice, Journal of Psychopharmacology, vol.105, issue.6, pp.635-679, 2007.
DOI : 10.1177/0269881106068825
URL : https://hal.archives-ouvertes.fr/inserm-00380032

R. Fradley, O. Meara, G. Newman, R. Andrieux, A. Job et al., STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating, Behavioural Brain Research, vol.163, issue.2, pp.257-64, 2005.
DOI : 10.1016/j.bbr.2005.05.012
URL : https://hal.archives-ouvertes.fr/inserm-00380197

C. Gong, S. Shaikh, I. Grundke-iqbal, and K. Iqbal, Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated ?? by neuroleptics, Brain Research, vol.741, issue.1-2, pp.95-102, 1996.
DOI : 10.1016/S0006-8993(96)00904-3

I. Gozes and I. Divinski, The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection, Journal of Alzheimer's Disease, vol.6, issue.s6, pp.37-41, 2004.
DOI : 10.3233/JAD-2004-6S605

I. Gozes, E. Giladi, A. Pinhasov, A. Bardea, and D. Brenneman, Activity-Dependent Neurotrophic Factor, J Pharmacol Exp Ther, vol.97, pp.1091-1099, 2000.
DOI : 10.1002/0471203076.emm0428

I. Gozes and U. Littauer, Tubulin microheterogeneity increases with rat brain maturation, Nature, vol.71, issue.5686, pp.411-414, 1978.
DOI : 10.1038/265653a0

I. Gozes, B. Morimoto, J. Tiong, A. Fox, K. Sutherland et al., NAP: Research and Development of a Peptide Derived from Activity-Dependent Neuroprotective Protein (ADNP), CNS Drug Reviews, vol.123, issue.4, pp.353-68, 2005.
DOI : 10.1111/j.1527-3458.2005.tb00053.x

I. Gozes, A. Stewart, B. Morimoto, A. Fox, K. Sutherland et al., Addressing Alzheimers Disease Tangles: From NAP to AL-108, Current Alzheimer Research, vol.6, issue.5, pp.455-60, 2009.
DOI : 10.2174/156720509789207895

P. Heiser, F. Enning, J. Krieg, and H. Vedder, Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro, Journal of Psychopharmacology, vol.143, issue.8, pp.851-857, 2007.
DOI : 10.1177/0269881107077221

D. Delotterie, G. Ruiz, J. Brocard, A. Schweitzer, C. Roucard et al., Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice, Psychopharmacology, vol.84, issue.1, pp.131-172, 2010.
DOI : 10.1007/s00213-009-1712-3
URL : https://hal.archives-ouvertes.fr/inserm-00447474

S. Mandel and I. Gozes, Activity-dependent Neuroprotective Protein Constitutes a Novel Element in the SWI/SNF Chromatin Remodeling Complex, Journal of Biological Chemistry, vol.282, issue.47, pp.34448-56, 2007.
DOI : 10.1074/jbc.M704756200

S. Mandel, I. Spivak-pohis, and I. Gozes, ADNP Differential Nucleus/Cytoplasm Localization in Neurons Suggests Multiple Roles in Neuronal Differentiation and Maintenance, Journal of Molecular Neuroscience, vol.123, issue.2, pp.127-168, 2008.
DOI : 10.1007/s12031-007-9013-y

Y. Matsuoka, Y. Jouroukhin, A. Gray, L. Ma, C. Hirata-fukae et al., A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease, Journal of Pharmacology and Experimental Therapeutics, vol.325, issue.1, pp.146-53, 2008.
DOI : 10.1124/jpet.107.130526

A. Pinhasov, S. Mandel, A. Torchinsky, E. Giladi, Z. Pittel et al., Activity-dependent neuroprotective protein: a novel gene essential for brain formation, Developmental Brain Research, vol.144, issue.1, pp.83-90, 2003.
DOI : 10.1016/S0165-3806(03)00162-7

H. Shimizu, Y. Iwayama, K. Yamada, T. Toyota, Y. Minabe et al., Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia, Schizophrenia Research, vol.84, issue.2-3, pp.244-52, 2006.
DOI : 10.1016/j.schres.2006.03.017

N. Shiryaev, Y. Jouroukhin, E. Giladi, E. Polyzoidou, N. Grigoriadis et al., NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model, Neurobiology of Disease, vol.34, issue.2, pp.381-389, 2009.
DOI : 10.1016/j.nbd.2009.02.011

V. Smith-swintosky, I. Gozes, D. Brenneman, D. Andrea, M. Plata-salaman et al., Activity-Dependent Neurotrophic Factor-9 and NAP Promote Neurite Outgrowth in Rat Hippocampal and Cortical Cultures, Journal of Molecular Neuroscience, vol.25, issue.3, pp.225-263, 2005.
DOI : 10.1385/JMN:25:3:225

I. Vulih-shultzman, A. Pinhasov, S. Mandel, N. Grigoriadis, O. Touloumi et al., Activity-Dependent Neuroprotective Protein Snippet NAP Reduces Tau Hyperphosphorylation and Enhances Learning in a Novel Transgenic Mouse Model, Journal of Pharmacology and Experimental Therapeutics, vol.323, issue.2, pp.438-487, 2007.
DOI : 10.1124/jpet.107.129551

I. Zemlyak, N. Manley, R. Sapolsky, and L. Gozes, NAP protects hippocampal neurons against multiple toxins, Peptides, vol.28, issue.10, pp.2004-2012, 2007.
DOI : 10.1016/j.peptides.2007.08.004